Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06393647 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Relationship Between Albumin/Creatine Ratio, B12, Folate, and Frailty Index

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 1 month later Oct 15, 2024 → Nov 15, 2026
Primary endpoint removed 2 → 1 primary endpoints
See other at-risk trials from Ankara Etlik City Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Oct 15, 2024 to Nov 15, 2026 Show 10 more changesShow less
    • Primary endpoint(s) modified
    • Enrollment increased: 40 → 80 participants
    • Trial status changed: Unknown → Recruiting
    • Study completion pushed from Nov 5, 2024 to Dec 1, 2026
    • Interventions modified
    • Trial arms changed: 2 → 1
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: 3 to 4
    • Study description shortened, about 18 words
    • Publications: details revised at 2 of 2 entries
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Trial status: Not Yet Recruiting to Unknownv2 Show 4 more changesShow less
    • Start date changed from estimate of May 15, 2024 to Jun 15, 2024
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised at 2 of 2 sites
    • Study description expanded, about 2 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In the literature, the relationship between frailty and various blood tests such as beta-2 microglobulin, CRP, procalcitonin, vitamin D, IL-1, and IL-6 has been investigated (2). In our study, the investigators aim to investigate the relationship between frailty status assessed using frailty scale forms (Frailty Scale Version 9) and preoperative levels of Albumin/Creatinine, B12, Folate, Ferritin, hemogram, Sedimentation Rate, and CRP in patients undergoing gastrointestinal malignancy surgery. By identifying the relationship among these parameters, the investigators believe that modifiable factors contributing to frailty in patients at risk can be addressed through appropriate interventions.
Trial Details
NCT Number NCT06393647
Lead Sponsor Ankara Etlik City Hospital
Conditions
(from sponsor)		 Frailty
Related terms Frailty
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov